152
RMDA: The Pharma Growth Engine 💊🚀

The Driver: High-margin growth in chronic treatments.
Revenue hit EGP 3.95B with steady institutional backing. 📈💰

Sharia Status: ✅ Compliant. A stable member of the EGX33 Shariah Index. ☪️📜

The Valuation: Trades at a premium P/E (~21x), reflecting its faster expansion vs. peers. 💎📊

The Technicals:
the 3.79 EGP level (61.8% Fibonacci). This is the last line of defense for the medium-term bullish structure. 📏🛡️
If 3.79 fails, the price is likely headed for a "Mean Reversion" at the 200-day Moving Average (at 3.4). 🧲📉


The Risk: Vulnerable to API import costs and currency-driven margin squeezes. ⚠️🏗️


If you like my posts, please follow and boost 🙌

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.